Medicine
Volume 38, Issue 6 , Pages 286-290, June 2010

Genital candidiasis

Jack D Sobel MD is a Distinguished Professor of Medicine and Chief of the Division of Infectious Diseases, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI, USA. Competing interests: none declared

Abstract 

Vulvovaginal candidiasis (vaginal thrush) remains an extremely common clinical problem, with both over- and under-diagnosis and unreliable self-diagnosis. Little progress has been made in providing diagnostic tests, and consequently inappropriate antifungal therapy is common. New genetic susceptibility mechanisms are emerging. No new antifungal drug regimens have recently appeared; accordingly, therapeutic recommendations are unchanged. Antifungal drug resistance fortunately remains rare.

Keywords: azole antifungals, candidosis, C. albicans, C. glabrata, genetic susceptibility, vaginal thrush, vulvovaginal candidiasis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1357-3039(10)00048-4

doi:10.1016/j.mpmed.2010.02.001

Medicine
Volume 38, Issue 6 , Pages 286-290, June 2010